Renaissance Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,172
Closed -$621K 246
2024
Q4
$621K Sell
1,172
-48,798
-98% -$27.5M 0.03% 189
2024
Q3
$30M Sell
49,970
-7,555
-13% -$4.28M 1.24% 49
2024
Q2
$31.2M Buy
57,525
+5,463
+10% +$3.13M 1.22% 44
2024
Q1
$33.4M Sell
52,062
-845
-2% -$513K 1.26% 40
2023
Q4
$30.9M Sell
52,907
-438
-0.8% -$245K 1.28% 35
2023
Q3
$27.7M Buy
53,345
+178
+0.3% +$92.5K 1.27% 42
2023
Q2
$28.8M Buy
53,167
+39
+0.1% +$21.3K 1.24% 40
2023
Q1
$28.6M Buy
53,128
+414
+0.8% +$211K 1.31% 35
2022
Q4
$26.9M Buy
52,714
+1,214
+2% +$591K 1.32% 36
2022
Q3
$22.5M Buy
+51,500
New +$24.8M 1.21% 49
2018
Q1
Sell
-1,932
Closed -$470K 284
2017
Q4
$470K Buy
1,932
+19
+1% +$4.32K 0.02% 194
2017
Q3
$387K Buy
+1,913
New +$376K 0.01% 222

Other funds holding CHE

Renaissance Group's CHE Position: Q1 2025 in Review

Renaissance Group sold out of Chemed (CHE) in Q1 2025, closing a stake of 1,172 shares — an estimated $621K sold.

Renaissance Group first reported a position in CHE in Q3 2017 and held it in 12 quarters. The position peaked at $33.4M in Q1 2024. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Renaissance Group reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
  • Renaissance Group sold 1,172 Chemed shares in Q1 2025, an estimated $621K.
  • Renaissance Group first reported a position in Chemed in Q3 2017 and held it in 12 quarters.
  • Renaissance Group's Chemed position peaked at $33.4M in Q1 2024.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Renaissance Group's 13F filing for Q1 2025, filed 13 May 2025.